317450 — Myung In Pharm Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩832bn
- KR₩346bn
- KR₩287bn
Annual cashflow statement for Myung In Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | — | 74,512 | 68,671 | 81,435 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | — | 14,339 | 23,435 | 16,989 |
| Unusual Items | ||||
| Purchased R&D | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 61,442 | -24,008 | -21,303 | -27,824 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | 61,442 | 76,027 | 83,018 | 81,311 |
| Capital Expenditures | -3,403 | -4,649 | -10,192 | -34,847 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | -85,543 | -35,161 | -66,703 | -228,682 |
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Cash from Investing Activities | -88,946 | -39,810 | -76,895 | -263,529 |
| Financing Cash Flow Items | -5,720 | -18,560 | -5,600 | -11,200 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | -7,211 | -20,019 | -7,675 | 181,113 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -34,716 | 16,198 | -1,552 | -1,105 |